These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17451980)

  • 21. A quantification of the placebo response in migraine prophylaxis.
    van der Kuy PH; Lohman JJ
    Cephalalgia; 2002 May; 22(4):265-70. PubMed ID: 12100088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical trial outcome in neuropathic pain: relationship to study characteristics.
    Katz J; Finnerup NB; Dworkin RH
    Neurology; 2008 Jan; 70(4):263-72. PubMed ID: 17914067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Migraine treatment and placebo effect.
    Speciali JG; Peres M; Bigal ME
    Expert Rev Neurother; 2010 Mar; 10(3):413-9. PubMed ID: 20187863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age effects on placebo response rates in clinical trials of acute agents for migraine: pooled analysis of rizatriptan trials in adults.
    Ho TW; Fan X; Rodgers A; Lines CR; Winner P; Shapiro RE
    Cephalalgia; 2009 Jul; 29(7):711-8. PubMed ID: 19210513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with the prophylactic effect of placebo injections in subjects enrolled in a study of botulinum toxin for migraine.
    Schwedt TJ; Hentz JG; Dodick DW
    Cephalalgia; 2007 Jun; 27(6):528-34. PubMed ID: 17459081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elimination of migraine-associated nausea in patients treated with rizatriptan orally disintegrating tablet (ODT): a randomized, double-blind, placebo-controlled study.
    Freitag F; Taylor FR; Hamid MA; Rodgers A; Hustad CM; Ramsey KE; Skobieranda F
    Headache; 2008 Mar; 48(3):368-77. PubMed ID: 18047500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New therapeutic alternatives in migraine prophylaxis using histamine H3 receptor agonists].
    Millán-Guerrero RO; Isais-Millán R
    Gac Med Mex; 2008; 144(4):291-5. PubMed ID: 18942262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Consequences of transforming measures of efficacy for acute therapies: 5-HT agonists as a worked example.
    Fox AW; Keywood C; Sheftell FD; Spierings EL
    Headache; 2004 Jan; 44(1):48-52. PubMed ID: 14979883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone.
    Dahabreh IJ; Economopoulos K
    Clin Trials; 2008; 5(2):116-20. PubMed ID: 18375649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous dexamethasone vs placebo as adjunctive therapy to reduce the recurrence rate of acute migraine headaches: a multicenter, double-blinded, placebo-controlled randomized clinical trial.
    Donaldson D; Sundermann R; Jackson R; Bastani A
    Am J Emerg Med; 2008 Feb; 26(2):124-30. PubMed ID: 18272089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use.
    Peniston JH; Gould E
    Clin Ther; 2009 Feb; 31(2):347-59. PubMed ID: 19302907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial.
    Lizogub VG; Riley DS; Heger M
    Explore (NY); 2007; 3(6):573-84. PubMed ID: 18005909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trial methodology and patient characteristics did not influence the size of placebo effects on pain.
    Kamper SJ; Machado LA; Herbert RD; Maher CG; McAuley JH
    J Clin Epidemiol; 2008 Mar; 61(3):256-60. PubMed ID: 18226748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tonabersat, a gap-junction modulator: efficacy and safety in two randomized, placebo-controlled, dose-ranging studies of acute migraine.
    Silberstein SD; Schoenen J; Göbel H; Diener HC; Elkind AH; Klapper JA; Howard RA
    Cephalalgia; 2009 Nov; 29 Suppl 2():17-27. PubMed ID: 19723122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Traditional acupuncture in migraine: a controlled, randomized study.
    Facco E; Liguori A; Petti F; Zanette G; Coluzzi F; De Nardin M; Mattia C
    Headache; 2008 Mar; 48(3):398-407. PubMed ID: 17868354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficiency of the cross-over design: an empirical estimation.
    Garcia R; Benet M; Arnau C; Cobo E
    Stat Med; 2004 Dec; 23(24):3773-80. PubMed ID: 15580599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Influence of placebo effect on planning and analysis of clinical trials].
    Macedo A; Sampaio C
    Rev Port Cardiol; 2001 Mar; 20(3):313-9. PubMed ID: 11417314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlled clinical trials of drugs for use in the prophylaxis of migraine.
    Hübbe P
    Dan Med Bull; 1975 Mar; 22(3):92-6. PubMed ID: 1093819
    [No Abstract]   [Full Text] [Related]  

  • 39. Meta-analysis combining parallel and cross-over clinical trials. II: Binary outcomes.
    Curtin F; Elbourne D; Altman DG
    Stat Med; 2002 Aug; 21(15):2145-59. PubMed ID: 12210630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unsubstantiated claims of large effects of placebo on pain: serious errors in meta-analysis of placebo analgesia mechanism studies.
    Hróbjartsson A; Gøtzsche PC
    J Clin Epidemiol; 2006 Apr; 59(4):336-8; discussion 339-41. PubMed ID: 16549252
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.